BRANDES INVESTMENT PARTNERS, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17,888,904
+9.4%
1,134,363
+34.9%
0.35%
+6.1%
Q2 2023$16,350,731
+5.7%
841,087
+54.3%
0.33%
+0.3%
Q1 2023$15,463,069
+27.1%
545,050
+31.0%
0.33%
-3.8%
Q4 2022$12,164,854
-1.6%
416,177
-11.0%
0.34%
+5.6%
Q3 2022$12,361,000
-40.1%
467,857
+0.8%
0.32%
-35.9%
Q2 2022$20,628,000
-3.5%
464,292
+7.5%
0.50%
+10.0%
Q1 2022$21,372,000
-31.7%
431,850
-29.7%
0.46%
-32.9%
Q4 2021$31,283,000
-16.7%
614,365
-8.7%
0.68%
-16.2%
Q3 2021$37,544,000
+22.4%
673,076
-6.1%
0.82%
+19.5%
Q2 2021$30,682,000
+52.6%
716,873
+46.4%
0.68%
+43.3%
Q1 2021$20,104,000
+63.5%
489,627
+85.2%
0.48%
+50.2%
Q4 2020$12,295,000
+86.8%
264,397
+70.7%
0.32%
+39.6%
Q3 2020$6,582,000
+1835.9%
154,924
+2084.8%
0.23%
+2170.0%
Q2 2020$340,000
-95.1%
7,091
-95.3%
0.01%
-95.9%
Q1 2020$6,928,000
+2120.5%
150,601
+2802.9%
0.24%
+3357.1%
Q4 2019$312,000
+7.6%
5,188
+1.1%
0.01%0.0%
Q3 2019$290,000
-29.6%
5,131
-30.6%
0.01%
-22.2%
Q2 2019$412,000
-62.9%
7,393
-66.4%
0.01%
-65.4%
Q1 2019$1,110,000
+29.4%
21,978
+3.1%
0.03%
+18.2%
Q4 2018$858,000
+237.8%
21,310
+482.6%
0.02%
+266.7%
Q3 2018$254,000
-72.0%
3,658
-69.5%
0.01%
-70.0%
Q2 2018$907,000
-31.7%
11,985
-52.5%
0.02%
-28.6%
Q1 2018$1,328,00025,2190.03%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders